{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00958",
      "entity_text" : "miR-146a",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:10376" ],
      "TissueType" : [ "tissuelist:TS-0771" ],
      "Cellular_component" : [ "go:GO:0018995" ],
      "Organ" : [ "uberon:UBERON:0000479" ]
    }
  },
  "verbose_text" : "XREF_BIBR, XREF_BIBR In the present study, we found that miR-146a expression levels in the peripheral blood of patients with GBS were significantly different from those in the healthy individuals, suggesting that miR-146a may be involved in the regulation of GBS, perhaps indicating a potential use of miRNA in clinical practice.",
  "reading_complete" : "2020-08-09T07:42:13Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-09T07:41:39Z",
  "trigger" : "levels",
  "evidence" : [ "miR-146a expression levels" ],
  "pmc_id" : "7133091",
  "score" : 0
}